• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year

    Continued Strong Demand Trends for Mission Critical Safety Equipment

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025.

    • Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025.
    • Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months ended June 30, 2025.
    • Net income of $12.2 million, or $0.30 per diluted share, for the second quarter; net income of $21.5 million, or $0.52 per diluted share, for the six months ended June 30, 2025.
    • Adjusted EBITDA of $27.0 million for the second quarter; Adjusted EBITDA of $47.5 million for the six months ended June 30, 2025.
    • Adjusted EBITDA margin of 17.2% for the second quarter; Adjusted EBITDA margin of 16.5% for the six months ended June 30, 2025.
    • Declared quarterly cash dividend of $0.095 per share in July 2025.

    "We delivered strong revenue growth and profitability in the second quarter, despite a fluid macro environment, which underscores the positive demand trends we continue to see for Cadre's best-in-class safety products across our law enforcement, first responder, military and nuclear categories," said Warren Kanders, CEO and Chairman. "Revenue and gross profit increased year-over-year by 9% and 10%, respectively. We remain confident that the combination of Cadre's track record of superior execution, resilience in the face of economic, political, geopolitical and other cycles, as well as our disciplined approach to capital allocation, will continue to drive strong results moving forward."

    Mr. Kanders added, "After completing the acquisition of multiple leading, niche global nuclear brands from Carr's Group in the second quarter, we are excited about the momentum in our nuclear safety business and opportunities to deepen our exposure to this attractive market segment. Today, the primary drivers of growth are related to significant environmental cleanup needs and expanding national defense programs, with the global upswing in nuclear power creating even greater demand for our suite of safety products and services in the future."

    Mr. Kanders concluded, "As we consider the Company's 2025 outlook, we have seen the timing of large opportunities shift more than in prior years, but we believe we are well positioned to continue to leverage our strong brands and drive growth over the long term. We expect our team's steadfast commitment to the Company's life-saving mission, constant innovation, and the principles of the Cadre operating model will drive superior performance. Additionally, with cash on the balance sheet of $137 million and undrawn revolver capacity of $175 million, Cadre is well positioned to capitalize on meaningful organic and inorganic growth opportunities ahead."

    Second Quarter and Six-Month 2025 Operating Results

    For the quarter ended June 30, 2025, Cadre generated net sales of $157.1 million, as compared to $144.3 million for the quarter ended June 30, 2024. This increase was primarily a result of recent acquisitions.

    For the six months ended June 30, 2025, Cadre generated net sales of $287.2 million, as compared to $282.2 million for the six months ended June 30, 2024, also mainly driven by recent acquisitions, as well as strong demand for nuclear safety and duty gear products, partially offset by large order shipment timing for explosive ordnance disposal ("EOD") and armor products.

    For the quarter ended June 30, 2025, Cadre generated gross profit of $64.2 million, as compared to $58.7 million for the quarter ended June 30, 2024. For the six months ended June 30, 2025, Cadre generated gross profit of $120.4 million, as compared to $116.3 million for the prior year period.

    Gross profit margin was 40.9% for the quarter ended June 30, 2025, as compared to 40.6% for the quarter ended June 30, 2024, mainly driven by favorable pricing and product mix, the absence of inventory step-up amortization, and exchange rate favorability. Gross profit margin was 41.9% for the six months ended June 30, 2025, as compared to 41.2% for the prior year period.

    Net income was $12.2 million for the quarter ended June 30, 2025, as compared to net income of $12.6 million for the quarter ended June 30, 2024. The decrease resulted primarily as a result of acquisition related costs offset by foreign exchange.

    Net income was $21.5 million for the six months ended June 30, 2025, as compared to net income of $19.5 million for the prior year period, also primarily as a result of foreign exchange offset by interest expense.

    Cadre generated $27.0 million of Adjusted EBITDA for the quarter ended June 30, 2025, as compared to $28.3 million for the quarter ended June 30, 2024. Adjusted EBITDA margin was 17.2% for the quarter ended June 30, 2025, as compared to 19.6% for the prior year period.

    Cadre generated $47.5 million of Adjusted EBITDA for the six months ended June 30, 2025, as compared to $52.8 million for the prior period. Adjusted EBITDA margin was 16.5% for the six months ended June 30, 2024, as compared to 18.7% for the prior year period.

    Product segment gross margin was 41.7% and 42.9% for the second quarter and first half of 2025, respectively, compared to 41.1% and 42.0% for the prior year periods.

    Distribution segment gross margin was 23.1% and 22.3% for the second quarter and first half of 2025, respectively, compared to 22.9% and 23.2% for the prior year periods.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents increased by $12.5 million from $124.9 million as of December 31, 2024 to $137.5 million as of June 30, 2025.
    • Total debt increased by $91.9 million from $223.2 million as of December 31, 2024 to $315.2 million as of June 30, 2025.
    • Net debt (total debt net of cash and cash equivalents) increased by $79.4 million from $98.3 million as of December 31, 2024 to $177.7 million as of June 30, 2025.
    • Capital expenditures totaled $1.3 million for the second quarter and $2.7 million for the six months ended June 30, 2025, compared with $2.1 million for the second quarter and $3.4 million for the six months ended June 30, 2024.

    Dividend

    On July 22, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on August 15, 2025 to shareholders of record as of the close of business on the record date of August 1, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    2025 Outlook

    For the full year 2025, Cadre expects to generate net sales in the range of $624 million to $630 million and Adjusted EBITDA in the range of $112 million and $116 million. We expect capital expenditures to be in the range of $7 million to $8 million. These ranges reflect our updated expectations around the timing of orders and do not incorporate impacts from the new tariffs announced July 31st and expected to be effective in August. Cadre has not provided net income guidance due to the inherent difficulty of forecasting certain types of expenses and gains, which affect net income but not Adjusted EBITDA. Therefore, we do not provide a reconciliation of Adjusted EBITDA guidance to net income guidance.

    Conference Call

    Management will host a conference call on Wednesday, August 6, 2025, at 10:00 a.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 9511718. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through August 20, 2025. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 9511718.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin and (iv) last twelve months adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2025 to net income for the fiscal year 2025, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    June 30, 2025

     

    December 31, 2024

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    137,469

     

    $

    124,933

     

    Accounts receivable, net of allowance for doubtful accounts of $905 and $876, respectively

     

     

    108,127

     

     

    93,523

     

    Inventories

     

     

    109,604

     

     

    82,351

     

    Prepaid expenses

     

     

    11,836

     

     

    19,027

     

    Other current assets

     

     

    13,980

     

     

    7,737

     

    Total current assets

     

     

    381,016

     

     

    327,571

     

    Property and equipment, net of accumulated depreciation and amortization of $58,658 and $54,384, respectively

     

     

    81,909

     

     

    45,243

     

    Operating lease assets

     

     

    21,314

     

     

    15,454

     

    Deferred tax assets, net

     

     

    4,917

     

     

    4,552

     

    Intangible assets, net

     

     

    126,411

     

     

    107,544

     

    Goodwill

     

     

    174,462

     

     

    148,157

     

    Other assets

     

     

    4,408

     

     

    4,192

     

    Total assets

     

    $

    794,437

     

    $

    652,713

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    32,004

     

    $

    29,644

     

    Accrued liabilities

     

     

    56,531

     

     

    46,413

     

    Income tax payable

     

     

    1,268

     

     

    6,693

     

    Current portion of long-term debt

     

     

    16,265

     

     

    11,375

     

    Total current liabilities

     

     

    106,068

     

     

    94,125

     

    Long-term debt

     

     

    298,885

     

     

    211,830

     

    Long-term operating lease liabilities

     

     

    15,645

     

     

    10,733

     

    Deferred tax liabilities

     

     

    30,306

     

     

    18,758

     

    Other liabilities

     

     

    11,073

     

     

    5,752

     

    Total liabilities

     

     

    461,977

     

     

    341,198

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024)

     

     

    —

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,663,844 and 40,607,988 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively)

     

     

    4

     

     

    4

     

    Additional paid-in capital

     

     

    310,099

     

     

    306,821

     

    Accumulated other comprehensive income (loss)

     

     

    2,540

     

     

    (1,389

    )

    Accumulated earnings

     

     

    19,817

     

     

    6,079

     

    Total shareholders' equity

     

     

    332,460

     

     

    311,515

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    794,437

     

    $

    652,713

     

     

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

     

    2025

     

    2024

     

    2025

     

    2024

    Net sales

     

    $

    157,109

     

     

    $

    144,309

     

     

    $

    287,215

     

     

    $

    282,169

     

    Cost of goods sold

     

     

    92,860

     

     

     

    85,659

     

     

     

    166,835

     

     

     

    165,891

     

    Gross profit

     

     

    64,249

     

     

     

    58,650

     

     

     

    120,380

     

     

     

    116,278

     

    Operating expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general and administrative

     

     

    45,129

     

     

     

    38,577

     

     

     

    86,882

     

     

     

    79,296

     

    Restructuring and transaction costs

     

     

    3,326

     

     

     

    19

     

     

     

    4,024

     

     

     

    3,106

     

    Related party expense

     

     

    1,109

     

     

     

    101

     

     

     

    1,237

     

     

     

    1,944

     

    Total operating expenses

     

     

    49,564

     

     

     

    38,697

     

     

     

    92,143

     

     

     

    84,346

     

    Operating income

     

     

    14,685

     

     

     

    19,953

     

     

     

    28,237

     

     

     

    31,932

     

    Other expense

     

     

     

     

     

     

     

     

     

     

     

     

    Interest expense

     

     

    (3,590

    )

     

     

    (2,003

    )

     

     

    (5,821

    )

     

     

    (3,640

    )

    Other income (expense), net

     

     

    6,114

     

     

     

    (336

    )

     

     

    7,401

     

     

     

    (1,780

    )

    Total other expense, net

     

     

    2,524

     

     

     

    (2,339

    )

     

     

    1,580

     

     

     

    (5,420

    )

    Income before provision for income taxes

     

     

    17,209

     

     

     

    17,614

     

     

     

    29,817

     

     

     

    26,512

     

    Provision for income taxes

     

     

    (4,998

    )

     

     

    (5,047

    )

     

     

    (8,358

    )

     

     

    (7,017

    )

    Net income

     

    $

    12,211

     

     

    $

    12,567

     

     

    $

    21,459

     

     

    $

    19,495

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.30

     

     

    $

    0.31

     

     

    $

    0.53

     

     

    $

    0.50

     

    Diluted

     

    $

    0.30

     

     

    $

    0.31

     

     

    $

    0.52

     

     

    $

    0.49

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

     

    40,661,955

     

     

     

    40,606,825

     

     

     

    40,640,433

     

     

     

    39,276,700

     

    Diluted

     

     

    40,941,790

     

     

     

    40,855,185

     

     

     

    40,960,025

     

     

     

    39,701,754

     

     

     

     

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30,

     

     

    2025

     

    2024

    Cash Flows From Operating Activities:

     

     

     

     

     

     

    Net income

     

    $

    21,459

     

     

    $

    19,495

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    8,532

     

     

     

    8,562

     

    Amortization of original issue discount and debt issue costs

     

     

    829

     

     

     

    502

     

    Amortization of inventory step-up

     

     

    356

     

     

     

    2,310

     

    Deferred income taxes

     

     

    266

     

     

     

    (1,915

    )

    Stock-based compensation

     

     

    4,393

     

     

     

    4,151

     

    Remeasurement of contingent consideration

     

     

    857

     

     

     

    509

     

    Provision for losses on accounts receivable

     

     

    40

     

     

     

    769

     

    Unrealized foreign exchange transaction (gain) loss

     

     

    (3,492

    )

     

     

    971

     

    Other loss

     

     

    152

     

     

     

    251

     

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

    Accounts receivable

     

     

    10,365

     

     

     

    (3,387

    )

    Inventories

     

     

    (11,304

    )

     

     

    2,355

     

    Prepaid expenses and other assets

     

     

    3,375

     

     

     

    705

     

    Accounts payable and other liabilities

     

     

    (15,849

    )

     

     

    (21,998

    )

    Net cash provided by operating activities

     

     

    19,979

     

     

     

    13,280

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (2,733

    )

     

     

    (3,365

    )

    Proceeds from disposition of property and equipment

     

     

    6

     

     

     

    49

     

    Business acquisitions, net of cash acquired

     

     

    (89,590

    )

     

     

    (141,813

    )

    Net cash used in investing activities

     

     

    (92,317

    )

     

     

    (145,129

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    —

     

     

     

    5,500

     

    Principal payments on revolving credit facilities

     

     

    —

     

     

     

    (5,500

    )

    Proceeds from term loans

     

     

    97,500

     

     

     

    80,000

     

    Principal payments on term loans

     

     

    (5,689

    )

     

     

    (6,065

    )

    Principal payments on insurance premium financing

     

     

    —

     

     

     

    (2,187

    )

    Payments for debt issuance costs

     

     

    —

     

     

     

    (844

    )

    Taxes paid in connection with employee stock transactions

     

     

    (1,185

    )

     

     

    (5,311

    )

    Proceeds from secondary offering, net of underwriter discounts

     

     

    —

     

     

     

    91,776

     

    Deferred offering costs

     

     

    —

     

     

     

    (683

    )

    Dividends distributed

     

     

    (7,721

    )

     

     

    (6,842

    )

    Other

     

     

    38

     

     

     

    37

     

    Net cash provided by financing activities

     

     

    82,943

     

     

     

    149,881

     

    Effect of foreign exchange rates on cash and cash equivalents

     

     

    1,931

     

     

     

    180

     

    Change in cash and cash equivalents

     

     

    12,536

     

     

     

    18,212

     

    Cash and cash equivalents, beginning of period

     

     

    124,933

     

     

     

    87,691

     

    Cash and cash equivalents, end of period

     

    $

    137,469

     

     

    $

    105,903

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    16,937

     

     

    $

    21,605

     

    Cash paid for interest

     

    $

    8,202

     

     

    $

    6,458

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    259

     

     

    $

    58

     

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    140,135

     

    $

    25,508

     

    $

    (8,534

    )

     

    $

    157,109

    Cost of goods sold

     

     

    81,702

     

     

    19,609

     

     

    (8,451

    )

     

     

    92,860

    Gross profit

     

    $

    58,433

     

    $

    5,899

     

    $

    (83

    )

     

    $

    64,249

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended June 30, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    128,433

     

    $

    25,588

     

    $

    (9,712

    )

     

    $

    144,309

    Cost of goods sold

     

     

    75,621

     

     

    19,723

     

     

    (9,685

    )

     

     

    85,659

    Gross profit

     

    $

    52,812

     

    $

    5,865

     

    $

    (27

    )

     

    $

    58,650

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30, 2025

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    252,870

     

    $

    53,370

     

    $

    (19,025

    )

     

    $

    287,215

    Cost of goods sold

     

     

    144,327

     

     

    41,450

     

     

    (18,942

    )

     

     

    166,835

    Gross profit

     

    $

    108,543

     

    $

    11,920

     

    $

    (83

    )

     

    $

    120,380

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Six Months Ended June 30, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    247,218

     

    $

    53,779

     

    $

    (18,828

    )

     

    $

    282,169

    Cost of goods sold

     

     

    143,385

     

     

    41,280

     

     

    (18,774

    )

     

     

    165,891

    Gross profit

     

    $

    103,833

     

    $

    12,499

     

    $

    (54

    )

     

    $

    116,278

     
    (1) Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year ended

     

    Three Months Ended

     

    Six Months Ended

     

    Last Twelve

     

     

    December 31,

     

    June 30,

     

    June 30,

     

    Months

     

     

    2024

     

    2025

     

    2024

     

    2025

     

    2024

     

    June 30, 2025

    Net income

     

    $

    36,133

     

    $

    12,211

     

     

    $

    12,567

     

     

    $

    21,459

     

     

    $

    19,495

     

    $

    38,097

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    16,420

     

     

    4,676

     

     

     

    4,620

     

     

     

    8,532

     

     

     

    8,562

     

     

    16,390

     

    Interest expense

     

     

    7,822

     

     

    3,590

     

     

     

    2,003

     

     

     

    5,821

     

     

     

    3,640

     

     

    10,003

     

    Provision for income taxes

     

     

    18,085

     

     

    4,998

     

     

     

    5,047

     

     

     

    8,358

     

     

     

    7,017

     

     

    19,426

     

    EBITDA

     

    $

    78,460

     

    $

    25,475

     

     

    $

    24,237

     

     

    $

    44,170

     

     

    $

    38,714

     

    $

    83,916

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    7,757

     

     

    4,326

     

     

     

    19

     

     

     

    5,024

     

     

     

    4,856

     

     

    7,925

     

    Other expense (income), net(2)

     

     

    4,721

     

     

    (6,114

    )

     

     

    336

     

     

     

    (7,401

    )

     

     

    1,780

     

     

    (4,460

    )

    Stock-based compensation expense(3)

     

     

    8,369

     

     

    2,425

     

     

     

    2,084

     

     

     

    4,393

     

     

     

    4,151

     

     

    8,611

     

    Stock-based compensation payroll tax expense(4)

     

     

    441

     

     

    —

     

     

     

    48

     

     

     

    92

     

     

     

    441

     

     

    92

     

    LTIP bonus(5)

     

     

    49

     

     

    —

     

     

     

    (1

    )

     

     

    —

     

     

     

    49

     

     

    —

     

    Amortization of inventory step-up(6)

     

     

    3,858

     

     

    356

     

     

     

    1,541

     

     

     

    356

     

     

     

    2,310

     

     

    1,904

     

    Contingent consideration expense(7)

     

     

    1,185

     

     

    526

     

     

     

    58

     

     

     

    857

     

     

     

    509

     

     

    1,533

     

    Adjusted EBITDA

     

    $

    104,840

     

    $

    26,994

     

     

    $

    28,322

     

     

    $

    47,491

     

     

    $

    52,810

     

    $

    99,521

     

    Adjusted EBITDA margin(8)

     

     

    18.5

    %

     

    17.2

    %

     

    19.6

    %

     

    16.5

    %

     

    18.7

    %

     

     

     

    (1)

    Reflects the "Restructuring and transaction costs" line item on our consolidated statements of operations, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.0 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Zircaloy for the three and six months ended June 30, 2025 and a $1.8 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety for the six months ended June 30, 2024, which are included in related party expense in the Company's condensed consolidated statements of operations.

    (2)

    Reflects the "Other income (expense), net" line item on our condensed consolidated statements of operations and primarily includes transaction gains and losses due to fluctuations in foreign currency exchange rates.

    (3)

    Reflects compensation expense related to equity and liability classified stock-based compensation plans.

    (4)

    Reflects payroll taxes associated with vested stock-based compensation awards.

    (5)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

    (6)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

    (7)

    Reflects contingent consideration expense related to the acquisition of ICOR.

    (8)

    Reflects Adjusted EBITDA / Net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250805572960/en/

    Gray Hudkins

    Cadre Holdings, Inc.

    203-550-7148

    [email protected]

    Investor Relations:

    The IGB Group

    Leon Berman / Matt Berkowitz

    212-477-8438 / 212-227-7098

    Get the next $CDRE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    8/12/25 4:16:56 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    8/6/25 11:56:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by Cadre Holdings Inc.

    10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

    8/5/25 4:16:50 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings Announces Participation at Upcoming Investor Conferences

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that Brad Williams, President, and Blaine Browers, Chief Financial Officer, are scheduled to participate in the following investor conferences in New York, NY: Jefferies Industrials Conference Date: Thursday, September 4, 2025 Presentation Time: 11:30 a.m. ET Webcast link 8th Annual B Riley Consumer & TMT Conference Date: Wednesday, September 10, 2025 Lake Street Capital Markets Best Ideas Growth Conference Date: Thursday, September 1

    8/21/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Second Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the second quarter that ended on June 30, 2025, on Tuesday, August 5, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, August 6, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To partici

    7/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO AND CHAIRMAN Kanders Warren B sold $819,500 worth of shares (25,000 units at $32.78) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/24/25 4:35:50 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $3,348,000 worth of shares (100,000 units at $33.48) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/23/25 4:15:18 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $4,200,750 worth of shares (125,000 units at $33.61) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/5/25 4:15:25 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Second Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the second quarter that ended on June 30, 2025, on Tuesday, August 5, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, August 6, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To partici

    7/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on August 15, 2025 to shareholders of record as of the close of business on the record date of August 1, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is

    7/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care